ELIXIR Innovation and SME Forum: Distributed Data Analysis - The (Health) Data Train
Start: Thursday, 10 October 2019 @ 09:00
End: Friday, 11 October 2019 @ 00:00
Venue: Jongerius Kantoor - Villa Jongerius
The Innovation and SME Forum on 10-11 October with a focus on “distributed data analysis - the (health) data train” in Utrecht is open to researchers working in the data driven life-science sector, large and small companies that develop services for data management and sharing, as well as people involved in national healthcare initiatives and anyone else who is interested in learning more about data-driven innovation in the life-science sector.
The concept of distributed data analysis as contained in the FAIR Data Train approach has been endorsed by the Dutch government in a letter to the Dutch Parliament in December 2018. Meanwhile, the Dutch Government is preparing to implement this novel strategy in the Dutch health care information system. This signals the emerging market for FAIR-based distributed analysis approaches beyond the science domain. The ELIXIR-NL public-private network is closely involved in specification and implementation.
This event contains a mix of high-level keynote speakers and interactive sessions to discuss and interact with other companies and ELIXIR partners. A specific session with Flash Talks, will give SMEs and Start-Ups the chance to introduce their work to a broad audience.
This event is a collaborative effort, organised by ELIXIR Netherlands (DTL) in collaboration with several DTL SME partners.
More generally, the event aims to inform about ELIXIR resources and create a space to network for industry and academia.
What people think about previous events:
"The ELIXIR Innovation and SME Forum was a great opportunity for us to interact with ELIXIR and also other SME organisations to share ideas and better understand how ELIXIR together with small and large companies can help bridging the "digital islands" of information and provide true value for life science stakeholders, researchers and in the ned, the patients." - Henrik Plym-Forshell, BC Platforms, Sweden